-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fusidic acid in Cystic Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fusidic acid in Cystic Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Fusidic acid in Cystic FibrosisDrug Details:Fusidic acid is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Fusidic Acid in Burkholderia pseudomallei Infections (Melioidosis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fusidic Acid in Burkholderia pseudomallei Infections (Melioidosis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fusidic Acid in Burkholderia pseudomallei Infections (Melioidosis) Drug Details:...
-
Product Insights
Eurobio Scientific SA Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Eurobio Scientific SA Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Eurobio Scientific SA (Eurobio), formerly Diaxonhit SA, is a biotechnology company that provides diagnostic products. The company provides products such as TQS, used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic infection. It develops other diagnostic products using its molecular biology platform such as Dx15, a molecular diagnostic test for thyroid cancer. Eurobio serves...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – fusidic acid
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry fusidic acid Drug Details Fusidic acid is under development for the treatment of melioidosis,...